reduction

Gome Fin Tech Announced Annual Results of 2023

Source Node:
Time Stamp: April 1, 2024 1:23 PM - Modified On: April 1, 2024 - Published By:
Source Cluster:
Republished By Plato

  Commercial Factoring Progresses Despite Stability Diversified Businesses Ready for Development HONG KONG, Mar 29, 2024 - (ACN Newswire) - Gome Finance Technology Co., Ltd.(Stock Code:628.HK,“Gome Fin Tech”or “the Company”,with its subsidiaries,the“Group”), announced its audited annual results for the year ended 31 December, 2023 (the “Reporting Period”). In 2023, the global geopolitical risks are frequent, the lack of economic recovery momentum and the widening trend of differentiation among countries are highlighted, and the risk spillover from European and US banks under the global high interest rate environment also casts a

Verofax facilitates Egyptian EU Export with CBAM Compliance and Lifecycle Assessment Solutions

Source Node:
Time Stamp: February 15, 2024 11:49 AM - Modified On: February 15, 2024 - Published By:
Source Cluster:
Republished By Plato

  Egyptian Businessmen's Association (EBA) convenes export symposium on February 9 CAIRO, Feb 15, 2024 - (ACN Newswire) - The Egyptian Businessmen's Association (EBA) convened a symposium on February 9, chaired by Engineer Majd al-Din al-Manzalawi, Secretary-General and Chairman of the Association’s Industry and Scientific Research Committee, to address the challenges and opportunities presented by the Carbon Border Adjustment Mechanism (CBAM), a law governing manufacturing standards for Egyptian exporters. [caption id="attachment_2481553" align="alignnone" width="780"] The Egyptian Businessmen's Association (EBA) convened to discuss the importance of technology in keeping factories compliant with export

A Note On Charity Through Marginal Price Discrimination

Source Node:
Time Stamp: February 2, 2024 11:16 AM - Modified On: February 2, 2024 - Published By:
Source Cluster:
Republished By Plato

Vitalik Buterin via the Vitalik Buterin Blog Updated 2018-07-28. See end note. The following is an interesting idea that I had two years ago that I personally believe has promise and could be easily implemented in the context of a blockchain ecosystem, though if desired it could certainly also be implemented with more traditional technologies (blockchains would help get the scheme network effects by putting the core logic on a more neutral platform). Suppose that you are a restaurant selling sandwiches, and you ordinarily sell sandwiches for $7.50. Why did

BitMask Wallet 0.7.0 Soars: A Quantum Leap in Bitcoin Evolution Surges Over 760,000 Wallets in Just One Month

Source Node:
Time Stamp: November 24, 2023 11:44 AM - Modified On: November 24, 2023 - Published By:
Source Cluster:
Republished By Plato

SAN FRANCISCO, November 23, 2023 (ACN Newswire) - DIBA Global, backed by industry titans including Draper Associates, ACTAI Ventures, Waterdrip Capital, Martial Eagle Fund, Brad Mills, Rodney Yesep, and others, has sent shockwaves through the Bitcoin industry with the beta release of BitMask Wallet 0.7.0. This marks a historic moment as the user base surpasses 763,623 wallets. This milestone, achieved without any advertising, underscores the community's trust in DIBA's commitment to advancing Bitcoin utility. Worthy of note is the official partnership between DIBA GLOBAL and Satoshi Lab to foster the development

Blockpass integrates award-winning ID system with Solana Wallets, offers special discount to Solana projects

Source Node:
Time Stamp: September 7, 2023 5:47 AM - Modified On: September 7, 2023 - Published By:
Source Cluster:
Republished By Plato

HONG KONG, Sept 7, 2023 - (ACN Newswire) - Blockpass has announced that it will be integrating its identity verification solution with Solana Wallets and supporting Solana projects with its revolutionary On-Chain KYC(R) solution. Additionally, Blockpass will provide a unique special offer available to all Solana projects in the form of a 50% discount. Solana is a blockchain network with the fundamental ideals of an open-source community, decentralization, staking and censorship resistance at its heart. The Solana network is validated by thousands of independently-operating nodes that ensures data remains secure

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:16 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Livento Group, Inc. Announces Second Quarter Results with Revenue Growth of Over 90%, Including Significant Achievements and Updates

Source Node:
Time Stamp: August 17, 2023 3:06 PM - Modified On: August 17, 2023 - Published By:
Source Cluster:
Republished By Plato

NEW YORK, NY / August 14, 2023 / NuGene International, Inc./Livento Group, Inc. (OTC Pink:NUGN), a dynamic leader specializing in the acquisition and development of companies with disruptive business models in film, content, and technology sectors, is pleased to announce revenue growth of 91.65% for the second quarter of 2023, compared to the same period in 2022. Financial Highlights: Revenue Growth:The second quarter ending June 30, 2023, saw revenues of $431,184, up from $224,986 in 2022. For the six-month period ending June 30, 2023, revenues grew from $680,202 to $922,651, a growth of

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:21 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

GMEX Group launches ZERO13 digital carbon credits aggregation ecosystem

Source Node:
Time Stamp: May 4, 2023 6:01 AM - Modified On: May 4, 2023 - Published By:
Source Cluster:
Republished By Plato

Partners with Verdana Eco-Consortium, Alléo Energy and Pay DIRT London., May. 4, 2023 -- GMEX Group Limited (“GMEX”), a leader in digital business and technology solutions for capital, commodities and sustainability markets, announces the launch of ZERO13, a climate fintech. ZERO13 provides an automated AI and multi-blockchain driven aggregation ecosystem delivering trusted supply, digital issuance, trading, clearing and settlement for a broad range of carbon credits and related ESG real-world assets. ZERO13 digitally interconnects multiple stakeholders, including registries, banks, custodians, asset managers, corporates, buyers and sellers, markets, exchanges, climate tech